Physician
Dermatology
Dr. Francisco A. Kerdel, MD
|
|
Give Review
Francisco Kerdel works in the field of Dermatology. He over the years received 5 awards: "Top Doctors:South Florida", "Top Doctors: Florida", "Fellow (FAAD)", "Super Doctor" and "Top MD". Francisco Kerdel is also published. He has 49 publications published. The lastest publication: "Localized vasculitis in newly formed striae: a unique manifestation of systemic lupus erythematosus.' Francisco Kerdel accepts Medicare payments and is listed with Medicare.gov.
Publications
- Localized vasculitis in newly formed striae: a unique manifestation of systemic lupus Erythematosus.
- Current and Emerging Nonsurgical Treatment Options for Hidradenitis Suppurativa.
- Association of Hidradenitis Suppurativa Disease Severity with Increased Risk for Systemic Comorbidities.
- Tumor necrosis factor inhibitors in psoriasis: an update.
- Diagnosis and treatment of psoriasis.
- Treatment of Giant Cellulitis-like Sweet Syndrome With Dapsone.
- Clinical Remission of Primary Aggressive CD8+ Cutaneous T-Cell Lymphoma After Pralatrexate Infusion.
- Post-kala-azar dermal leishmaniasis in HIV-infected patients with AIDS: a report of two cases diagnosed in the USA.
- Psoriasis treated with ustekinumab in a patient with hepatitis C.
- Ustekinumab for the treatment of Nail psoriasis in heavily treated psoriatic patients.
- Pityriasis rubra pilaris: Was it the first manifestation of colon cancer in a patient with pre-existing psoriasis?
- Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
- Sister Mary joseph nodule as a presenting sign of pancreatobiliary adenoCarcinoma.
- Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasis.
- The use of cyclosporine in dermatology.
- The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label...
- Use of intravenous immunoglobulin in toxic epidermal necrolysis: comment on "in a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve surv...
- Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus Erythematosus.
- An unusual case of cutaneous hyaline-vascular castleman's disease with multicentric involvement and systemic symptoms.
- Human T-lymphotropic Virus 1 (HTLV-1) Infection - dermatological implications.
- Painful generalized Erythematous patches: a severe and unusual cutaneous reaction to pemetrexed.
- Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label ...
- Ustekinumab: when everything else fails?
- Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil.
- A prospective open-label clinical trial of adalimumab for the treatment of Hidradenitis suppurativa.
- Botryomycosis-like pyoderma in the genital region of a human immunodeficiency virus (HIV)-positive man successfully treated with dapsone.
- Infliximab therapy for patients with moderate to severe Hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
- Pyoderma gangrenosum--rebel without a cure?
- Acute generalized exanthematous pustulosis due to clindamycin.
- Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination.
- Infectious disease update: new anti-microbials.
- Etanercept and psoriasis, from clinical studies to real life.
- Eccrine syringofibroadenoma of clear Cell variant: an immunohistochemical study.
- Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
- Poor prognosis of arthritis-associated pyoderma gangrenosum.
- Successful treatment of Von Zumbusch pustular psoriasis with infliximab.
- Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States.
- Microbiologic evaluation of Skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period.
- Exogenous lipoid pneumonia caused by facial application of petrolatum.
- Cutaneous Wegener's Granulomatosis (malignant pyoderma) in a patient with Crohn's disease.
- Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus Erythematosus: rapid response to rituximab.
- Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses.
- Intravenous immunoglobulin for the treatment of toxic epidermal necrolysis.
- Hospitalization for severe Skin disease improves quality of life in the United Kingdom and the United States: a comparative study.
- Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
- Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience.
- Topical targretin and intraLesional interferon alfa for cutaneous lymphoma of the scalp.
- Immunoablative high-dose cyclophosphamide without stem Cell rescue in pemphigus foliaceus.
Schools
Kings College London School of Medicine
St Thomas Hospital
Harvard University
Guys Hospital
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Top Doctors:South Florida
- Top Doctors: Florida
- Fellow (FAAD)
- Super Doctor
- Top MD
Education
-
Massachusetts General Hospital
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1144258724 | |
| NPPES Provider LastName | KERDEL | |
| NPPES Provider FirstName | FRANCISCO | |
| NPPES Provider ZIPCode | 331361003 | |
| NPPES Provider State | FL | |
| Specialty Description | Dermatology | |
| Total Claim Count | 4365.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 0.41 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144258724 |
| Last Name Of The Provider | KERDEL |
| First Name Of The Provider | FRANCISCO |
| View All |
Similar Doctors
|
|
Dr. Elizabeth A. Lebrun, MD |
|
|
Dr. Jacquelyn R. Dosal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mercedes Aguiar, MD |
|
|
Dr. Caroline Y. Winslow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rivka C. Stone, MD
This Doctor is OpenDoctor Recommended.
|